Bluejay Diagnostics, Inc. Common Stock

BJDXNASDAQ • USD
ThemeMedical Devices & HealthTech›Diagnostic Imaging & Equipment
4.34 USD
↗ 2.17 (99.82%)🟢LIVE (AS OF 01:40 PM EDT)
🟢Market: OPEN
Open?$6.12
High?$8.00
Low?$2.12
Prev. Close?$2.17
Volume?70.5M
Avg. Volume?55.5K
VWAP?$5.98
Rel. Volume?1,269.91x
Bid / Ask
Bid?$4.43 × 100
Ask?$4.47 × 100
Spread?$0.04
Midpoint?$4.45
Valuation & Ratios
Market Cap?2.2M
Shares Out?1.0M
Float?2.4M
Float %?90.0%
P/E Ratio?N/A
P/B Ratio?0.54
EPS?-$6.67
Dividend?0.00%
Ex-Dividend?N/A

Bluejay Diagnostics, Inc. Common Stock (BJDX) is currently trading at $4.34. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 2, 2026.

News
Profile
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Themes
Medical Devices & HealthTech›Diagnostic Imaging & Equipment
Employees
6
Market Cap
2.2M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.bluejaydx.com
Listed
2021-11-10
Address
360 MASSACHUSETTS AVENUE, SUITE 203
ACTON, MA 01720
Phone: (978) 631-0152
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?-13.49Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.29%Low
Short Interest?6.8K
Days to Cover?1.0
Free Float2.4M
Avg Daily Volume32.4K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.81Strong
Quick Ratio?2.81Strong
Cash Ratio?2.61Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.54CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-165.1%WEAK▾
ROA?
S&P
3
-123.3%WEAK▾
Cash Flow & Enterprise
FCF?$-6650642
Enterprise Value?$-1439125
Fundamentals ratios updated end of day
MarketsMoversWatchlist